You're reading the free version. Trader adds the live tape and alerts.
Start tracking
KYMR Sale Disclosure
Goodman Noah · SEC Form 4 · Filed Jul 2, 2026
Sale
Calculated transaction value
$387.33K
Goodman Noah Chief Business Officer
KYMR
Kymera Therapeutics
KYMR
Transaction date
Jul 1, 2026
Public filing date
Jul 2, 2026
Filing lag
Filed 1 day later
KYMR daily price context
Close on/before transaction
$114.2
Jul 1, 2026
First close after public filing
$114.76
Jul 6, 2026
30-day return after filing
-12.59%
Through Aug 3, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 3,389 shares @ $114.29
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-295089
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$387.33K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Kymera Therapeutics, Inc. KYMR Current | Sale | Jul 1, 2026 | $387.33K |